No Data
Express News | Zai Lab Ltd - to Handle Commercialization Activities for Povetacicept
Express News | Zai Lab Ltd - Vertex to Receive Upfront Payment, Milestone Payments, and Royalties
Zai Lab Inks Strategic Partnership With Medilink Therapeutics
Reported Earlier, Zai Lab Expands Oncology Pipeline With MediLink Collaboration For Novel LRRC15 ADC ZL-6201
Hong Kong stocks movement | ZAI LAB (09688) rose over 5%. Institutions are bullish on its commercialization and innovative research and development, initially rating it as 'Buy'.
ZAI LAB (09688) rose more than 5%, as of the time of writing, an increase of 5.01%, priced at 20.35 Hong Kong dollars, with a transaction amount of 51.4273 million Hong Kong dollars.
Zai Lab Secures 300 Million Yuan Debt Facility